参考文献/References:
[1]Sbaraglia M,Bellan E,Dei Tos AP.The 2020 WHO Classification of Soft Tissue Tumours: news and perspectives.Pathologica,2021,113(2):70-84.
[2]Thway K.Welldifferentiated liposarcoma and dedifferentiated liposarcoma:an updated review.Semin Diagn Pathol,2019,36(2):112-121.
[3]Xiao J,Liu J,Chen M,et al.Diagnosis and prognosis of retroperitoneal liposarcoma: a single asian center cohort of 57 cases.J Oncol,2021,2021:7594027.
[4]徐晓林,薛利芳.腹膜后脂肪肉瘤声像图特征的临床意义.中国超声医学杂志,2019,35(8):727-720.
[5]Yee EJ,Stewart CL,Clay MR,et al.Lipoma and its doppelganger: the atypical lipomatous tumor/welldifferentiated liposarcoma.Surg Clin North Am,2022,102(4):637-656.
[6]Parkes A,Urqelola E,Bhosale P,et al.PET/CT imaging as a diagnostic tool in distinguishing welldifferentiated versus dedifferentiated liposarcoma.Sarcoma,2020,2020: 8363986.
[7]Kawaguchi M,Kato H,Kobayashi K,et al.MRI findings to differentiate musculoskeletal dedifferentiated liposarcoma from atypical lipomatous tumor.Radiol Med,2022,127(12):1383-1389.
[8]Zhuang A,Zhuang A,Wu Q,et al.Prognostic factor analysis and nomogram construction of primary retroperitoneal liposarcoma: a review of 10 years of treatment experience in a single asian cohort of 211 cases.Front Oncol,2021,11:777647.
[9]Zhuang A,Wu Q,Tong H,et al.Development and validation of a nomogram for predicting recurrencefree survival of surgical resected retroperitoneal liposarcoma.Cancer Manag Res,2021,13:6633-6639.
[10]Xue G,Wang Z,Li C,et al.A novel nomogram for predicting local recurrencefree survival after surgical resection for retroperitoneal liposarcoma from a Chinese tertiary cancer center.Int J Clin Oncol,2021,26(1):145-153.
[11]Italiano A,Toulmonde M,CioffiI A,et al.Advanced welldifferentiated/dedifferentiated liposarcomas: role of chemotherapy and survival.Multicenter Study,2012,23(6):1601-1607.
[12]Callegaro D,Raut CP,Ajayi T,et al.Preoperative radiotherapy in patients with primary retroperitoneal sarcoma:EORTC62092 trial (STRASS) versus offtrial (STREXIT) results.Ann Surg,2022 Jul 14.Epub ahead of print.
[13]王雪,于胜吉.脂肪肉瘤的研究进展.癌症进展,2022,20(22):2269-2271.
[14]Mansfield SA,Pollock RE,Grignol VP.Surgery for abdominal welldifferentiated liposarcoma.Curr Treat Options Oncol,2018,19(1):1.
[15]Tseng WW,Swallow CJ,Strauss DC,et al.Management of locally recurrent retroperitoneal sarcoma in the adult:an updated consensus approach from the Transatlantic Australasian Retroperitoneal Sarcoma Working Group.Ann Surg Oncol,2022,29(12):7335-7348.
[16]Fairweather M,Gonzalez RJ,Strauss D,et al.Current principles of surgery for retroperitoneal sarcomas.J Surg Oncol,2018,117(1):33-41.
[17]Gronchi A,Lo Vullo S,Fiore M,et al.Aggressive surgical policies in a retrospectively reviewed singleinstitution case series of retroperitoneal soft tissue sarcoma patients.J Clin Oncol,2009,27(1):24-30.
[18]Bonvalot S,RivoireI M,Castaing M,et al.Primary retroperitoneal sarcomas:a multivariate analysis of surgical factors associated with local control.J Clin Oncol,2009,27(1):31-37.
[19]Karadayi K,Yildiz C,Karakus S,et al.Welldifferentiated abdominal liposarcoma:experience of a tertiary care center.World J Surg Oncol,2015,13:166.
[20]厉学民,於敏,周海华,等.经腹入路腹腔镜在原发性腹膜后肿瘤切除术中的应用研究.浙江医学,2022,44(3):296-298,302.
[21]谢学海,陈依然,马永蔌,等.腹腔镜经腹入路和经腹膜外入路在肾下极水平以上原发性腹膜后肿瘤切除术中的应用.中国微创外科杂志,2019,19(3):232-235.
[22]Oh SD,Oh SJ,Suh BJ,et al.A giant retroperitoneal liposarcoma encasing the entire left kidney and adherent to adjacent structures:a case report.Case Rep Oncol,2016,9(2):368-372.